⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNCX News
Quince Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
IRLA
QNCX
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease
globenewswire.com
QNCX
Form 8-K
sec.gov
QNCX
Form 8-K
sec.gov
QNCX
Form 8-K
sec.gov
QNCX
GSK
AZN
ZYME
TNYA
NTAP
EXEL
NVS
KLRS
NKTX
CLYM
INSM
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
globenewswire.com
QNCX
Form 8-K
sec.gov
QNCX
Form 8-K
sec.gov
QNCX
Quince Therapeutics to Participate in September 2026 Investor Conferences
globenewswire.com
QNCX
Form 8-K
sec.gov
QNCX